[ORGANIZATION]
Hypera
Featured in 4 tracked stories · first seen
Situations
Brazil plans semaglutide integration into SUS
8 clusters · 117 sources · last updated
Latest: GLP-1 weight loss drug prescriptions surge 304.9% in Brazil
The Brazilian Ministry of Health is progressing with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). On September 24, 2026, the Ministry submitted a formal request to
Retail sector digital and media transformation
2 clusters · 4 sources · last updated
Latest: Retail sector undergoes digital and media transformation
The retail sector is experiencing a digital and media transformation characterized by omnichannel strategies, data integration, and artificial intelligence. In the pharmaceutical niche, industry leaders recently conven
Semaglutide regulatory approvals and pricing in Brazil
8 clusters · 112 sources · last updated
Latest: Brazil expands access to obesity and diabetes treatments
Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject
Also covered in
-
Hypera and Bradsaúde see positive outlooks from financial analysts
[BUSINESS] · 5 sources ·